ODI PHARMA AB Cash Flow Reinvestment Rate
ODI PHARMA AB cash flow reinvestment rate. ODI PHARMA AB (6OD) has a Cash Flow Reinvestment Rate of 0.00x as of June 2026, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €364.19K. Explore 6OD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ODI PHARMA AB (2026–2026)
Cash flow reinvestment rate of ODI PHARMA AB from 2026 to 2026. Historical reinvestment intensity for ODI PHARMA AB across 1 annual periods. Also explore ODI PHARMA AB (6OD) equity growth momentum to track the company's year-over-year net asset growth rate.
ODI PHARMA AB Cash Flow Reinvestment Rate by Year (2026–2026)
ODI PHARMA AB cash flow reinvestment rate by year from 2026 to 2026. Year-by-year capital reinvestment analysis for ODI PHARMA AB. For the full cash flow conversion analysis, see ODI PHARMA AB (6OD) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.00x | €0.00 | €4.58 Million | €0.00 | — |